⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14087030 | 0.94 | — | — | |
| SCHEMBL16731361 | 0.78 | — | — | |
| SCHEMBL15899109 | 0.78 | — | — | |
| SCHEMBL24309180 | 0.78 | — | — | |
| SCHEMBL141116 | 0.78 | — | — | |
| SCHEMBL18138135 | 0.75 | — | — | |
| SCHEMBL8225474 | 0.75 | — | — | |
| SCHEMBL23717055 | 0.71 | — | — | |
| SCHEMBL17067973 | 0.71 | CHRNA7 (0.37) | — | |
| SCHEMBL24654708 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4561307-A1 | PEROVSKITE SOLAR CELL WITH LOCAL SEMI-OPEN PASSIVATION CONTACT STRUCTURE AND PREPARATION METHOD THEREFOR | University of Science and Technology of China (CN) | 2025-05-28 | — | — | EP | claimed |
| US-20250169269-A1 | PEROVSKITE SOLAR CELLS WITH LOCAL SEMI-OPENING PASSIVATION CONTACT STRUCTURE AND PREPARATION METHOD THEREOF | UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA (CN) | 2025-05-22 | — | — | US | claimed |
| CN-115884607-A | Perovskite solar cell with local semi-open passivation contact structure and preparation method thereof | 中国科学技术大学 | 2023-03-31 | — | — | CN | claimed |
| EP-4561307-A1 | PEROVSKITE SOLAR CELL WITH LOCAL SEMI-OPEN PASSIVATION CONTACT STRUCTURE AND PREPARATION METHOD THEREFOR | University of Science and Technology of China (CN) | 2025-05-28 | — | — | EP | disclosed |
| US-20250169269-A1 | PEROVSKITE SOLAR CELLS WITH LOCAL SEMI-OPENING PASSIVATION CONTACT STRUCTURE AND PREPARATION METHOD THEREOF | UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA (CN) | 2025-05-22 | — | — | US | disclosed |
| CN-119767994-A | Passivation process of perovskite layer and preparation process of perovskite solar cell | 深圳市曼恩光电科技有限公司 | 2025-04-04 | — | — | CN | disclosed |
| EP-4327882-A2 | ENPP1 INHIBITORS AND THEIR USE FOR THE TREATMENT OF CANCER | The Board of Trustees of the Leland Stanford Junior University (US) | 2024-02-28 | — | — | EP | disclosed |
| EP-4289428-A1 | NITROGEN-CONTAINING POLYCYCLIC FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF | Applied Pharmaceutical Science, Inc. (CN) | 2023-12-13 | — | — | EP | disclosed |
| WO-2023184327-A1 | KINASE INHIBITORS, PREPARATION METHODS AND USES THEREOF | InventisBio Co., Ltd. (CN) | 2023-10-05 | — | — | WO | disclosed |
| US-20230203018-A1 | COVALENT INHIBITORS OF KRAS | ARAXES PHARMA LLC (US) | 2023-06-29 | — | — | US | disclosed |
| WO-2023077083-A1 | ENPP1 INHIBITORS AS INHIBITORS OF METASTASIS | ANGARUS THERAPEUTICS, INC. (US) | 2023-05-04 | — | — | WO | disclosed |
| US-9884817-B2 | Auristatin derivatives and conjugates thereof | NOVARTIS AG (CH) | 2018-02-06 | — | — | US | disclosed |
| WO-2017195428-A1 | NOVEL COMPOUND, PHOTOCURABLE COMPOSITION, CURED PRODUCT THEREOF, PRINTING INK, AND PRINTED MATTER USING PRINTING INK | DIC株式会社 | 2017-11-16 | — | — | WO | disclosed |
| US-20170158702-A1 | MULTIVALENT RAS BINDING COMPOUNDS | KYRAS THERAPEUTICS, INC. | 2017-06-08 | — | — | US | disclosed |
| US-20170121282-A1 | AURISTATIN DERIVATIVES AND CONJUGATES THEREOF | NOVARTIS AG (CH) | 2017-05-04 | — | — | US | disclosed |
| WO-2016094628-A1 | ASSAYS FOR BTK INHIBITORS | MERCK PATENT GMBH (DE) | 2016-06-16 | — | — | WO | disclosed |
| WO-2015061247-A2 | HETEROARYL COMPOUNDS AS BTK INHIBITORS AND USES THEREOF | MERCK PATENT GMBH (DE) | 2015-04-30 | — | — | WO | disclosed |
| WO-2012087428-A1 | POLYAMIDE MEMBRANES VIA INTERFACIAL POLYMERSATION WITH MONOMERS COMPRISING A PROTECTED AMINE GROUP | GENERAL ELECTRIC COMPANY (US) | 2012-06-28 | — | — | WO | disclosed |
| WO-2011102436-A1 | TGF-Β SIGNAL TRANSDUCTION INHIBITOR | 国立大学法人京都大学 (JP) | 2011-08-25 | — | — | WO | disclosed |
| WO-2010062264-A1 | LIPOPEPTIDE COMPOUNDS AND THEIR USE | MERLION PHARMACEUTICALS PTE LTD (SG) | 2010-06-03 | — | — | WO | disclosed |